Prescient Therapeutics Ltd (ASX:PTX)

APAC company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - PTX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - PTX

  • Market CapAUD0.000m
  • SymbolASX:PTX
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINAU000000PTX3

Company Profile

Prescient Therapeutics Ltd is a clinical-stage oncology company. The company develops novel compounds for the treatment of a range of cancers in Australia. Its product in the pipeline includes OmniCAR; PTX-100 and PTX-200. OmniCAR is a universal immune receptor platform enabling controllable T-cell activity and multi-antigen targeting with a single cell product.Prescient Therapeutics Ltd is a clinical stage oncology company engaged in developing & commercialising novel products to improve standard cancer treatments.

Latest PTX news

Currently there for this company. Visit our news hub for other news .